Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)

NCT00104273 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

376

Enrollment

INDUSTRY

Sponsor class

Conditions

Dementia
Alzheimer's Disease

Interventions

DRUG: Rasagiline

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.

Collaborators

[object Object]